82 FR 50435 - Office of the Director, National Institutes of Health; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 209 (October 31, 2017)

[Federal Register Volume 82, Number 209 (Tuesday, October 31, 2017)]
[Notices]
[Page 50435]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-23641]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Office of AIDS 
Research Advisory Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as 
amended, for the review of recommendations for the HHS Treatment and 
Prevention Guidelines for medical care of people living with HIV in the 
United States. Recommendations made from the working group to the OARAC 
will include drug names, treatment regimens, and prevention modalities 
to be used for the clinical care of PLWHA. The Council may revise the 
draft guidelines and change the content or scope of treatment and 
prevention for HIV/AIDS as recommended in the final guidelines. 
Premature disclosure of draft guidelines in an open meeting could 
negatively impact health and safety due to the premature disclosure of 
information to medical providers and the public. Draft guidelines could 
be misunderstood and confuse medical providers and the public as to 
what is the current HHS guidelines for the treatment and prevention of 
HIV/AIDS, could lead to premature changes in treatment regimens and 
prevention modalities that affect the health and safety of PLWHA and 
the public.

    Name of Committee: Office of AIDS Research Advisory Council.
    Date: November 16, 2017.
    Open: 8:30 a.m. to 12:00 p.m.
    Agenda: OAR Director's Report, updates from the DHHS HIV 
Treatment and Prevention Guidelines, OAR Task Force on Cost Sharing, 
and plans for the Clinical Trials Networks from the National 
Institute of Allergy and Infectious Diseases.
    Place: National Institutes of Health, Room ID13, 5601 Fishers 
Lane, Bethesda, MD 20892.
    Closed: 12:30 p.m. to 1:00 p.m.
    Agenda: To evaluate and review recommendations for the HHS 
Treatment and Prevention Guidelines.
    Place: National Institutes of Health, Room ID13, 5601 Fishers 
Lane, Bethesda, MD 20892.
    Open: 1:00 p.m. to 4:30 p.m.
    Agenda: Update from the National Heart, Lung, and Blood 
Institute on the merger of the MACS and WIHS, and updates on HIV/
AIDS Research Activities from the Eunice Kennedy Shriver National 
Institute of Child Health and Human Development and the National 
Institute on Aging.
    Place: National Institutes of Health Room ID13, 5601 Fishers 
Lane, Bethesda, MD 20892.
    Contact Person: Elizabeth S. Church, Ph.D., Executive Secretary 
, Office of AIDS Research, DPCPSI, Office of the Director, 5601 
Fishers Lane, Room 2E-60, Rockville, MD 20852-9830, 240-627-3201, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: www.oar.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: October 26, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-23641 Filed 10-30-17; 8:45 am]
BILLING CODE 4140-01-P